Carvedilol vs. Propranolol in Second Prophylaxis of Variceal Bleeding
Conditions: Portal Hypertension; Varice Bleed; Cirrhosis, Liver Interventions: Drug: Carvedilol; Drug: Propranolol Sponsors: West China Hospital; Chengdu Shangjin Nanfu Hospital; West China Tianfu Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 15, 2022 Category: Research Source Type: clinical trials
Propranolol in Combination With Pembrolizumab and Standard Chemotherapy for the Treatment of Unresectable Locally Advanced or Metastatic Esophageal or Gastroesophageal Junction Adenocarcinoma
Conditions: Clinical Stage II Esophageal Adenocarcinoma AJCC v8; Clinical Stage III Esophageal Adenocarcinoma AJCC v8; Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8; Clinical Stage IV Esophageal Adenocarcinoma AJCC v8; Clinical Stage IV Gastroesophageal Junction Adenocarcin oma AJCC v8; Locally Advanced Esophageal Adenocarcinoma; Locally Advanced Gastroesophageal Junction Adenocarcinoma; Metastatic Esophageal Adenocarcinoma; Metastatic Gastroesophageal Junction Adenocarcinoma; Unresectable Esophageal Adenocarcinoma; Unresectable Gastroesophagea l Junction Adenoc...
Source: ClinicalTrials.gov - December 15, 2022 Category: Research Source Type: clinical trials
Carvedilol vs. Propranolol in Second Prophylaxis of Variceal Bleeding
Conditions: Portal Hypertension; Varice Bleed; Cirrhosis, Liver Interventions: Drug: Carvedilol; Drug: Propranolol Sponsors: West China Hospital; Chengdu Shangjin Nanfu Hospital; West China Tianfu Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 15, 2022 Category: Research Source Type: clinical trials
Propranolol in Combination With Pembrolizumab and Standard Chemotherapy for the Treatment of Unresectable Locally Advanced or Metastatic Esophageal or Gastroesophageal Junction Adenocarcinoma
Conditions: Clinical Stage II Esophageal Adenocarcinoma AJCC v8; Clinical Stage III Esophageal Adenocarcinoma AJCC v8; Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8; Clinical Stage IV Esophageal Adenocarcinoma AJCC v8; Clinical Stage IV Gastroesophageal Junction Adenocarcin oma AJCC v8; Locally Advanced Esophageal Adenocarcinoma; Locally Advanced Gastroesophageal Junction Adenocarcinoma; Metastatic Esophageal Adenocarcinoma; Metastatic Gastroesophageal Junction Adenocarcinoma; Unresectable Esophageal Adenocarcinoma; Unresectable Gastroesophagea l Junction Adenoc...
Source: ClinicalTrials.gov - December 15, 2022 Category: Research Source Type: clinical trials
Carvedilol vs. Propranolol in Second Prophylaxis of Variceal Bleeding
Conditions: Portal Hypertension; Varice Bleed; Cirrhosis, Liver Interventions: Drug: Carvedilol; Drug: Propranolol Sponsors: West China Hospital; Chengdu Shangjin Nanfu Hospital; West China Tianfu Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 15, 2022 Category: Research Source Type: clinical trials
Propranolol in Combination With Pembrolizumab and Standard Chemotherapy for the Treatment of Unresectable Locally Advanced or Metastatic Esophageal or Gastroesophageal Junction Adenocarcinoma
Conditions: Clinical Stage II Esophageal Adenocarcinoma AJCC v8; Clinical Stage III Esophageal Adenocarcinoma AJCC v8; Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8; Clinical Stage IV Esophageal Adenocarcinoma AJCC v8; Clinical Stage IV Gastroesophageal Junction Adenocarcin oma AJCC v8; Locally Advanced Esophageal Adenocarcinoma; Locally Advanced Gastroesophageal Junction Adenocarcinoma; Metastatic Esophageal Adenocarcinoma; Metastatic Gastroesophageal Junction Adenocarcinoma; Unresectable Esophageal Adenocarcinoma; Unresectable Gastroesophagea l Junction Adenoc...
Source: ClinicalTrials.gov - December 15, 2022 Category: Research Source Type: clinical trials
Carvedilol vs. Propranolol in Second Prophylaxis of Variceal Bleeding
Conditions: Portal Hypertension; Varice Bleed; Cirrhosis, Liver Interventions: Drug: Carvedilol; Drug: Propranolol Sponsors: West China Hospital; Chengdu Shangjin Nanfu Hospital; West China Tianfu Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 15, 2022 Category: Research Source Type: clinical trials
Propranolol in Combination With Pembrolizumab and Standard Chemotherapy for the Treatment of Unresectable Locally Advanced or Metastatic Esophageal or Gastroesophageal Junction Adenocarcinoma
Conditions: Clinical Stage II Esophageal Adenocarcinoma AJCC v8; Clinical Stage III Esophageal Adenocarcinoma AJCC v8; Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8; Clinical Stage IV Esophageal Adenocarcinoma AJCC v8; Clinical Stage IV Gastroesophageal Junction Adenocarcin oma AJCC v8; Locally Advanced Esophageal Adenocarcinoma; Locally Advanced Gastroesophageal Junction Adenocarcinoma; Metastatic Esophageal Adenocarcinoma; Metastatic Gastroesophageal Junction Adenocarcinoma; Unresectable Esophageal Adenocarcinoma; Unresectable Gastroesophagea l Junction Adenoc...
Source: ClinicalTrials.gov - December 15, 2022 Category: Research Source Type: clinical trials
Carvedilol vs. Propranolol in Second Prophylaxis of Variceal Bleeding
Conditions: Portal Hypertension; Varice Bleed; Cirrhosis, Liver Interventions: Drug: Carvedilol; Drug: Propranolol Sponsors: West China Hospital; Chengdu Shangjin Nanfu Hospital; West China Tianfu Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 15, 2022 Category: Research Source Type: clinical trials
Propranolol in Combination With Pembrolizumab and Standard Chemotherapy for the Treatment of Unresectable Locally Advanced or Metastatic Esophageal or Gastroesophageal Junction Adenocarcinoma
Conditions: Clinical Stage II Esophageal Adenocarcinoma AJCC v8; Clinical Stage III Esophageal Adenocarcinoma AJCC v8; Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8; Clinical Stage IV Esophageal Adenocarcinoma AJCC v8; Clinical Stage IV Gastroesophageal Junction Adenocarcin oma AJCC v8; Locally Advanced Esophageal Adenocarcinoma; Locally Advanced Gastroesophageal Junction Adenocarcinoma; Metastatic Esophageal Adenocarcinoma; Metastatic Gastroesophageal Junction Adenocarcinoma; Unresectable Esophageal Adenocarcinoma; Unresectable Gastroesophagea l Junction Adenoc...
Source: ClinicalTrials.gov - December 15, 2022 Category: Research Source Type: clinical trials
Carvedilol vs. Propranolol in Second Prophylaxis of Variceal Bleeding
Conditions: Portal Hypertension; Varice Bleed; Cirrhosis, Liver Interventions: Drug: Carvedilol; Drug: Propranolol Sponsors: West China Hospital; Chengdu Shangjin Nanfu Hospital; West China Tianfu Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 15, 2022 Category: Research Source Type: clinical trials
Propranolol in Combination With Pembrolizumab and Standard Chemotherapy for the Treatment of Unresectable Locally Advanced or Metastatic Esophageal or Gastroesophageal Junction Adenocarcinoma
Conditions: Clinical Stage II Esophageal Adenocarcinoma AJCC v8; Clinical Stage III Esophageal Adenocarcinoma AJCC v8; Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8; Clinical Stage IV Esophageal Adenocarcinoma AJCC v8; Clinical Stage IV Gastroesophageal Junction Adenocarcin oma AJCC v8; Locally Advanced Esophageal Adenocarcinoma; Locally Advanced Gastroesophageal Junction Adenocarcinoma; Metastatic Esophageal Adenocarcinoma; Metastatic Gastroesophageal Junction Adenocarcinoma; Unresectable Esophageal Adenocarcinoma; Unresectable Gastroesophagea l Junction Adenoc...
Source: ClinicalTrials.gov - December 15, 2022 Category: Research Source Type: clinical trials
Carvedilol vs. Propranolol in Second Prophylaxis of Variceal Bleeding
Conditions: Portal Hypertension; Varice Bleed; Cirrhosis, Liver Interventions: Drug: Carvedilol; Drug: Propranolol Sponsors: West China Hospital; Chengdu Shangjin Nanfu Hospital; West China Tianfu Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 15, 2022 Category: Research Source Type: clinical trials
Propranolol in Combination With Pembrolizumab and Standard Chemotherapy for the Treatment of Unresectable Locally Advanced or Metastatic Esophageal or Gastroesophageal Junction Adenocarcinoma
Conditions: Clinical Stage II Esophageal Adenocarcinoma AJCC v8; Clinical Stage III Esophageal Adenocarcinoma AJCC v8; Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8; Clinical Stage IV Esophageal Adenocarcinoma AJCC v8; Clinical Stage IV Gastroesophageal Junction Adenocarcin oma AJCC v8; Locally Advanced Esophageal Adenocarcinoma; Locally Advanced Gastroesophageal Junction Adenocarcinoma; Metastatic Esophageal Adenocarcinoma; Metastatic Gastroesophageal Junction Adenocarcinoma; Unresectable Esophageal Adenocarcinoma; Unresectable Gastroesophagea l Junction Adenoc...
Source: ClinicalTrials.gov - December 15, 2022 Category: Research Source Type: clinical trials
Carvedilol vs. Propranolol in Second Prophylaxis of Variceal Bleeding
Conditions: Portal Hypertension; Varice Bleed; Cirrhosis, Liver Interventions: Drug: Carvedilol; Drug: Propranolol Sponsors: West China Hospital; Chengdu Shangjin Nanfu Hospital; West China Tianfu Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 15, 2022 Category: Research Source Type: clinical trials